Reports

2981 Results (Page 1 of 120)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

South Africa Dermatological Therapeutics Market Analysis

South Africa Dermatological Therapeutics Market is at around $0.27 Bn in 2022 and is projected to reach $0.52 Bn in 2030, exhibiting a CAGR of 9.83% during the forecast period. The market is expanding due to a rise in the elderly population, increased awareness and education, and a surge in dermatological conditions. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Dermatological Therapeutics Market Analysis

Kenya Dermatological Therapeutics Market is at around $0.03 Bn in 2023 and is projected to reach $0.06 Bn in 2030, exhibiting a CAGR of 9.7% during the forecast period. The expansion of the market is driven by factors such as government initiatives, healthcare infrastructure development, changing lifestyles, and environmental factors. The market is dominated by key players like Glenmark Pharmaceuticals, Universal Pharmaceuticals Limited, Cosmos Limited, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Dermatological Therapeutics Market Analysis

Egypt Dermatological Therapeutics Market is at around $0.12 Bn in 2023 and is projected to reach $0.23 Bn in 2030, exhibiting a CAGR of 10.10% during the forecast period. The factors driving the expansion of the market are rising awareness, the prevalence of skin disorders, and advancements in treatment technologies. The market is dominated by key players like Egyptian International Pharmaceutical Co. (EPICO), Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Dermatological Therapeutics Market Analysis

Vietnam Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.37 Bn in 2030, exhibiting a CAGR of 8.83% during the forecast period. Advances in technology, the prevalence of skin disorders, and increased awareness of skin health are driving the expansion of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc (GSK), AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Singapore Dermatological Therapeutics Market Analysis

Singapore Dermatological Therapeutics Market is at around $0.05 Bn in 2023 and is projected to reach $0.09 Bn in 2030, exhibiting a CAGR of 9.2% during the forecast period. The market is expanding as a result of the prevalence of skin conditions, rising awareness, and consumer preferences for aesthetic procedures. The market is dominated by key players like Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Dermatological Therapeutics Market Analysis

Philippines Dermatological Therapeutics Market is at around $0.09 Bn in 2023 and is projected to reach $0.17 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The market is expanding due to factors such as the aging population, changing lifestyles, and an increase in dermatological conditions. The market is dominated by key players like Unilab, Mercury Drug Corporation, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Malaysia Dermatological Therapeutics Market Analysis

Malaysia Dermatological Therapeutics Market is at around $0.07 Bn in 2023 and is projected to reach $0.12 Bn in 2030, exhibiting a CAGR of 8.8% during the forecast period. The market is being driven by rising healthcare awareness, an increase in dermatological conditions, and technological advancements. The market is dominated by key players like Pharmaniaga Berhad, Duopharma Biotech Berhad, Almirall SA, Pfizer Inc., GlaxoSmithKline Plc, AbbVie Inc., Amgen Inc., Novartis AG, Roche, Sanofi, Bayer, and Johnson & Johnson.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Dermatological Therapeutics Market Analysis

Japan Dermatological Therapeutics Market is at around $2.56 Bn in 2023 and is projected to reach $4.71 Bn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The market is being driven by an increasing aging population, a growing prevalence of dermatological disorders, and technological advancements in treatment options. The market is dominated by key players like Takeda Pharmaceutical Company Limited (JPN), Shionogi & Co., Ltd. (JPN), Eisai Co., ltd. (JPN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Dermatological Therapeutics Market Analysis

Indonesia Dermatological Therapeutics Market is at around $0.25 Bn in 2023 and is projected to reach $0.44 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is expanding due to an increase in dermatological disorders, increased awareness about skin diseases, and technological advancements. The market is dominated by key players like PT Kalbe Farma Tbk (IDN), PT Kimia Farma Tbk (IDN), PT Sanbe Farma (IDN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Dermatological Therapeutics Market Analysis

China Dermatological Therapeutics Market is at around $3.34 Bn in 2023 and is projected to reach $6.54 Bn in 2030, exhibiting a CAGR of 10.1% during the forecast period. The market is growing as a result of urbanization, increasing elderly population, and growing awareness. The market is dominated by key players like Fosun Pharma (CHN), Sinopharm (CHN), Jiangsu Hengrui Medicine (CHN), CSPC Pharmaceutical Group (CHN), Hualan Biological Engineering (CHN), Harbin Pharmaceutical Group (CHN), Yunna Baiyao Group (CHN), Sino Biopharmaceutical (CHN), Pfizer, Johnson & Johnson, Novartis AG, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UK Dermatological Therapeutics Market Analysis

UK Dermatological Therapeutics Market is at around $1.04 Bn in 2023 and is projected to reach $1.63 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The market is driven by the rising prevalence of skin disorders, developments in dermatology research and technology, and patient awareness and education. The market is dominated by key players like LEO Pharma, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, Johnson & Johnson, Eli Lilly and Company, and GlaxoSmithKline Plc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Dermatological Therapeutics Market Analysis

Spain Dermatological Therapeutics Market is at around $0.78 Bn in 2023 and is projected to reach $1.31 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is expanding due to factors such as trends in cosmetic dermatology, healthcare infrastructure and access to dermatological care, and advancements in dermatology technology. The market is dominated by key players like Skin Tech Pharma, Grupo Juste, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Germany Dermatological Therapeutics Market Analysis

Germany Dermatological Therapeutics Market is at around $1.47 Bn in 2023 and is projected to reach $2.34 Bn in 2030, exhibiting a CAGR of 6.8% during the forecast period. The market is being driven by an aging population, an increase in dermatological conditions, and advances in research and development. The market is dominated by key players like Beiersdorf, Stada Arzneimittel, Merck KGaA, Boehringer Ingelheim, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, and Gladerma Laboratories.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Dermatological Therapeutics Market Analysis

France Dermatological Therapeutics Market is at around $1.12 Bn in 2022 and is projected to reach $1.86 Bn in 2030, exhibiting a CAGR of 7.6% during the forecast period. The market is propelling due to the rising incidence of dermatological conditions, increasing awareness about skin disorders, and growing demand for cosmetic dermatology. The market is dominated by key players like Pierre Fabre (France), Boiron (France), Lallemand Pharma (France), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Gladerma Laboratories, and Bausch Health Companies Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Dermatological Therapeutics Market Analysis

Mexico Dermatological Therapeutics Market is at around $0.62 Bn in 2022 and is projected to reach $1.11 Bn in 2030, exhibiting a CAGR of 8.85% during the forecast period. The market is rapidly expanding as a result of the increased prevalence of dermatological conditions, rising awareness about skin disorders, and technological advancements in the industry. The market is dominated by key players like Genomma Lab Internacional, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma Laboratories, Bausch Health Companies Inc., Novartis AG, Eli Lily and Company, and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Dermatological Therapeutics Market Analysis

Brazil Dermatological Therapeutics Market is at around $1.03 Bn in 2023 and is projected to reach $1.96 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is growing due to factors such as rising dermatological disorders, e-commerce and digital marketing, and technological advancements. The market is dominated by key players like Hypermarcas, Ache Laboratorios Farmaceuticos S.A., EMS: Industria Farmaceutica S.A., Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Dermatological Therapeutics Market Analysis

UAE Dermatological Therapeutics Market is at around $0.21 Bn in 2023 and is projected to reach $0.39 Bn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The market is being driven by advancements in dermatological research, medical tourism, and growing awareness of skin health. The market is dominated by key players like Neopharma, Julphur, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Dermatological Therapeutics Market Analysis

Saudi Arabia Dermatological Therapeutics Market is at around $0.71 Bn in 2023 and is projected to reach $1.38 Bn in 2030, exhibiting a CAGR of 10.1% during the forecast period. The market is expanding due to trends in cosmetic dermatology, supportive regulatory frameworks, and growing distribution networks. The market is dominated by key players like Jamjoom Pharma Company, Tabuk Pharmaceutical Manufacturing Company, Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Canada Dermatological Therapeutics Market Analysis

Canada Dermatological Therapeutics Market is at around $3.28 Bn in 2023 and is projected to reach $5.84 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is growing due to factors such as the rising prevalence of skin disorders, the aging population, and technological developments. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Dermatological Therapeutics Market Analysis

US Dermatological Therapeutics Market is at around $16.88 Bn in 2023 and is projected to reach $26.40 Bn in 2030, exhibiting a CAGR of 6.6% during the forecast period. The development of innovative therapies, the growing trend of cosmetic dermatology, and the increasing prevalence of skin conditions are driving the growth of the market. The market is dominated by key players like Almirall SA, Pfizer Inc., AbbVie Inc., Amgen, Gladerma SA, Johnson & Johnson, Novartis AG, Eli Lily and Company, Sun Pharmaceuticals Ltd., and GlaxoSmithKline PLC.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Vitamin and Minerals Market Analysis

This report presents a strategic analysis of the US Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the US Vitamin and Minerals Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Lung Cancer Drugs Market Analysis

US Lung Cancer Drug Market is projected to grow from $4.015 Bn in 2022 to $6.546 Bn by 2030, registering a CAGR of 6.3% during the forecast period of 2022-30. The incidence of lung cancer is increasing globally, which is leading to a growing demand for lung cancer drugs in the US market. Key players operating in the market include Pfizer, Bristol-Myers Squibb, Merck, AstraZeneca, and Roche.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Diabetes Therapeutics Market Analysis

US's diabetes therapeutics market is projected to grow from $60.4 Bn in 2022 to $109.4 Bn by 2030, registering a CAGR of 7.7% during the forecast period of 2022-30. Diabetes is a chronic disease that affects millions of people in the US. According to the Centers for Disease Control and Prevention (CDC), over 34 million people in the US have diabetes, and the prevalence of the disease is increasing. This has led to an increase in demand for diabetes therapeutics. Some of the key players in the US diabetes therapeutics market include Novo Nordisk, Sanofi, Eli Lilly and Company, AstraZeneca, and Merck & Co. These companies are focusing on research and development activities to introduce new and innovative drugs and therapies to address the unmet needs of diabetic patients.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Cardiovascular Drugs Market Analysis

Indonesia Cardiovascular Drug Market is at around $0.83 Bn in 2022 and is projected to reach $1.12 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The main elements propelling this industry's growth include the incidence of cardiovascular diseases, changing lifestyles, and the aging population. The market is dominated by key players like Kalbe Pharma, Kimia Pharma, Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, and Gilead Sciences, Inc.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Anemia Therapeutics Market Analysis

The Brazil Anemia Therapeutics Market is anticipated to experience growth from $370 Mn in 2022 to $799 Mn by 2030, with a CAGR of 10.10% during the forecast period of 2022–2030. Factors such as the demography and disease burden in Brazil, increasing adaptation of healthcare innovations and advancements, and lenient and fast regulatory policies, drive market growth. The Brazil Anemia Therapeutics Market encompasses various players across different segments, including Amgen, Roche, Novartis, Eli Lilly, Sanofi, Cristalia Pharma, Ache Laboratories, EMS Pharma, Eurofarma, BioLab Pharma, etc, among various others

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up